-
Study aim
-
Evaluating the Effectiveness of Online and In-Person Transdiagnostic Group Therapy (Unified Protocol) on Transdiagnostic Components in Patients with Multiple Sclerosis Comorbid with Depression and Anxiety
-
Design
-
A phase 2, randomized, two side blinded, parallel-group clinical trial on 40 patients.
-
Settings and conduct
-
The intervention will be conducted at the Omid Zanjan Charity in a group format for MS patients to improve their quality of life, consisting of 12 sessions. Each session will last 45 minutes. According to the Unified Protocol for Transdiagnostic Treatment by Barlow, the modules and the specified number of sessions for each module will be implemented. To minimize bias in outcome assessment and data analysis, a "blinding of outcome assessor and data analyst" method was used.
-
Participants/Inclusion and exclusion criteria
-
MS diagnosis confirmed by a neurologist؛Minimum middle school education؛ No substance use disorders؛ No other concurrent psychotherapy؛ Age 20-40 years؛ No severe psychiatric disorders؛ Ambulatory (EDSS <6.5)؛ BDI-II score of 0-16 (mild-moderate depression)؛ BAI score of 0-25 (mild-moderate anxiety)
Development of new severe psychiatric conditions؛MS relapse or increase in EDSS to ≥6.5؛ Absence from more than 2 sessions؛ Acute psychological crisis؛ Increase in BDI-II score to >16 or BAI score to >25
-
Intervention groups
-
In this study, participants in the intervention group will receive 12 therapy sessions, each lasting 45 minutes. The first intervention group will attend these sessions in person, while the second group will participate online. The primary focus of the sessions will be on cognitive restructuring, body awareness, present-moment awareness (mindfulness), teaching the concepts of opposite action, and the three components of emotion, which include thoughts, bodily sensations, and behaviors.
-
Main outcome variables
-
Depression and anxiety severity؛ MS-related quality of life